Latest filing published 17 Aug 2026 for Accenture plc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Nancy McKinstry (board member) discloses dealings in 3 companies, chiefly Accenture plc, Abbott Laboratories and Mondelez International, Inc. Over a trading history stretching from 14 May 2021 to 14 August 2026, the count stands at 42 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 17 August 2026, the filings show a share grant in Accenture plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 42 declarations